Names | |
---|---|
IUPAC name
Thioacetamide
|
|
Preferred IUPAC name
Ethanethioamide
|
|
Other names
acetothioamide, TAA, thioacetimidic acid, TA, TAM
|
|
Identifiers | |
3D model (Jmol)
|
|
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.000.493 |
KEGG | |
PubChem CID
|
|
RTECS number | AC8925000 |
UNII | |
|
|
|
|
Properties | |
C2H5NS | |
Molar mass | 75.13 g/mol |
Appearance | cristalls colourless crystals |
Odor | slight mercaptan |
Density | 1.269 g/cm3 |
Melting point | 115 °C (239 °F; 388 K) |
Boiling point | decomposes |
good | |
-42.45·10−6 cm3/mol | |
Structure | |
monoclinic | |
Hazards | |
Main hazards | Foul stench, carcinogenic |
Safety data sheet | MSDS |
R-phrases (outdated) | R22, R36, R37, R45 |
S-phrases (outdated) | S45, S53 |
Related compounds | |
Related compounds
|
acetamide, dithioacetic acid |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Thioacetamide is an organosulfur compound with the formula C2H5NS. This white crystalline solid is soluble in water and serves as a source of sulfide ions in the synthesis of organic and inorganic compounds. It is a prototypical thioamide.
Thioacetamide was widely used in classical qualitative inorganic analysis as an in situ source for sulfide ions. Thus, treatment of aqueous solutions of many metal cations to a solution of thioacetamide affords the corresponding metal sulfide:
Related precipitations occur for sources of soft trivalent cations (As3+, Sb3+, Bi3+) and monovalent cations (Ag+, Cu+).
Thioacetamide is prepared by treating acetamide with phosphorus pentasulfide as shown in the following idealized reaction:
The C2NH2S portion of the molecule is planar; the C-S and C-N distances are 1.713 and 1.324 Å, both indicating multiple bonding.
Thioacetamide is carcinogen class 2B. It is known to produce marked hepatotoxicity in exposed animals. Toxicity values are 301 mg/kg in rats (LD50, oral administration), 300 mg/kg in mice (LD50, intraperitoneal administration). This is evidenced by enzymatic changes, which include elevation in the levels of serum alanine transaminase, aspartate transaminase and aspartic acid.